Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with chronic kidney disease (CKD) who may have or have been diagnosed with calciphylaxis (a serious condition affecting blood vessels and skin):
- People aged 18 or older
- People who have chronic kidney disease (CKD)
- People where there is a suspicion of, or a recent diagnosis of, calciphylaxis, as agreed upon by the relevant medical specialists involved in their care
- People who are able to understand and agree to take part in a study, as assessed by the local research team
- People who are willing and able to provide written consent to participate
For people with chronic kidney disease (CKD) acting as a comparison group:
- People aged 18 or older
- People who have chronic kidney disease (CKD)
- People who are able to understand and agree to take part in a study, as assessed by the local research team
- People who are willing and able to provide written consent to participate
For the healthy reference group:
- People aged 18 or older
- People who consider themselves to be in good health, confirmed by the local research team at the time of joining
Who may not be able to join:
- People in the calciphylaxis group whose diagnosis of calciphylaxis is later ruled out by medical specialists
- People in the CKD comparison group who have been diagnosed with calciphylaxis
- People in the healthy reference group who are aged 60 or under and have kidney function test results below a certain level (eGFR below 60 ml/min/1.73m²) (confirm with trial site)
- People in the healthy reference group who are over 60 years of age and have kidney function test results below a range considered normal for their age, based on Danish nephrology reference standards (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Subagini Nagarajah, PhD, Odense University Hospital
Phone: +45 40498337
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All-cause mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.